ALCEDIAG biomarkers for better health

Medical and psychiatric diagnosis

EDITDIAG, a blood test to diagnose depression and suicidal behavior

To assist medical staff during diagnosis and patient management phases
To accompany pharmaceutical companies during drug development stages

The RNA editing company

ALCEDIAG has unique experience and expertise in RNA editing

More than ten years of R&D
Successful clinical trials
Several publications
Registered and granted patents worldwide

Biomarkers for psychiatry

A unique set of proprietary biomarkers to revolutionize personalized medicine in psychiatry

Medical and psychiatric diagnosis

EDITDIAG, a blood test to diagnose depression and suicidal behavior

To assist medical staff during diagnosis and patient management phases
To accompany pharmaceutical companies during drug development stages

The RNA editing company

ALCEDIAG has unique experience and expertise in RNA editing

More than ten years of R&D
Successful clinical trials
Several publications
Registered and granted patents worldwide

Biomarkers for psychiatry

A unique set of proprietary biomarkers to revolutionize personalized medicine in psychiatry

New ALCEDIAG scientific article discussing EDITOX technology

Emerging RNA editing biomarkers
will foster drug development

Need more informations?

You are *

First name *

Last name *

E-mail *

Company

Message *

News last one

09 jan 2017

Harvard study published in Environmental Health

Congress next one

25 to 27 mar 2019

Bio-Europe Spring

website

Medical and psychiatric diagnosis

The RNA editing company

Biomarkers for psychiatry

Medical and psychiatric diagnosis

The RNA editing company

Biomarkers for psychiatry

Emerging RNA editing biomarkers
will foster drug development

Need more informations?

News last one

Harvard study published in Environmental Health

Congress next one

Bio-Europe Spring

ALCEDIAG's scientifics publications

ALCEDIAG's
scientifics publications